0001161697-15-000242.txt : 20150526 0001161697-15-000242.hdr.sgml : 20150525 20150526171740 ACCESSION NUMBER: 0001161697-15-000242 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20150520 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150526 DATE AS OF CHANGE: 20150526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VISUALANT INC CENTRAL INDEX KEY: 0001074828 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 911948357 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30262 FILM NUMBER: 15890232 BUSINESS ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 420 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-903-1351 MAIL ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 420 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: Visualant, INC DATE OF NAME CHANGE: 20050106 FORMER COMPANY: FORMER CONFORMED NAME: STARBERRYS CORP DATE OF NAME CHANGE: 20020918 FORMER COMPANY: FORMER CONFORMED NAME: CIGAR KING CORP DATE OF NAME CHANGE: 19990127 8-K 1 form_8-k.htm FORM 8-K FOR 05-20-2015

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report: May 20, 2015


    VISUALANT, INCORPORATED    

(Exact name of Registrant as specified in its charter)


    Nevada    

    0-25541    

    90-0273142    

(State or jurisdiction of incorporation)

(Commission File No.)

(IRS Employer Identification No.)


500 Union Street, Suite 420

Seattle, Washington 98101

                (206) 903-1351                

(Address of Registrant’s principal executive office and telephone number)




Section 8 – Other Events


Item 8.01 Other Events.


Issuance of Eight Patent on its ChromaID™ technology


On May 26, 2015, Visualant, Inc. (the “Company”), a provider of chromatic-based identification and diagnostic solutions, announced today that it has received its eighth patent on its ChromaID™ technology.


This patent is the continuation of the original series of patents filed by Visualant on the ChromaID technology beginning in 2007.  This patent protects the application of the ChromaID technology in the fields of manufacturing, process quality control, authentication of financial and identity documents, use with biological tissues related to diagnosis and security as well as the deterioration of manufactured materials and monitoring of liquids, fuels, and lubricants.  The patent also details methods for networking the functioning of the ChromaID technology for database building and access for comparing data acquired by one ChromaID device with those collected by other devices.  This patent solidifies Visualant’s patent portfolio in terms of extending the original ChromaID inventions to these various application domains.


The patent issued by the United States Office of Patents and Trademarks is US Patent No. 8,988,666 and is entitled “Method, Apparatus, and Article to Facilitate Evaluation of Objects Using Electromagnetic Energy.”


Item 9.01 Financial Statements and Exhibits.


(d)     Exhibits –


Exhibit No.

Description

 

 

99.1

Press Release of Visualant, Inc. dated May 26, 2015 related to the eight patent award for the ChromaID™ technology.



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Registrant: VISUALANT, INCORPORATED

 

 

 

 

By:

/s/ Ronald P. Erickson

 

 

Ronald P. Erickson, CEO


May 26, 2015


- 2 -


EX-99 2 ex_99-1.htm PRESS RELEASE DATED 05-26-2015

Exhibit 99.1


Visualant Granted Eighth Patent:  Continues Expansion of Patent Portfolio


Patent Covers Large Markets in Manufacturing, Process Control and Authentication


Seattle, WA. – (May 26, 2015) Visualant, Inc. (OTCQB: VSUL) – an industry-leading provider of chromatic-based identification and diagnostic solutions, announced today that it has received its eighth patent on its ChromaID™ technology.


This patent is the continuation of the original series of patents filed by Visualant on the ChromaID technology beginning in 2007.  This patent protects the application of the ChromaID technology in the fields of manufacturing, process quality control, authentication of financial and identity documents, use with biological tissues related to diagnosis and security as well as the deterioration of manufactured materials and monitoring of liquids, fuels, and lubricants.  The patent also details methods for networking the functioning of the ChromaID technology for database building and access for comparing data acquired by one ChromaID device with those collected by other devices.  This patent solidifies Visualant’s patent portfolio in terms of extending the original ChromaID inventions to these various application domains.


Visualant’s ChromaID technology was invented when Dr. Thomas Furness, a professor at the University of Washington and pioneer in the field of virtual reality, recognized that every material exhibited a unique light signature when stimulated by visible and invisible structured coherent light sources. Dr. Furness and his team continue to work with Visualant to extend the reach of its foundational ChromaID technology.  This newly issued patent is a part of that effort.


The patent issued by the United States Office of Patents and Trademarks is US Patent No. 8,988,666 and is entitled “Method, Apparatus, and Article to Facilitate Evaluation of Objects Using Electromagnetic Energy.”


Ron Erickson, Visualant Founder and CEO stated, “This latest patent is further validation of our intellectual property.  Our patent portfolio is a core element of Visualant’s asset base.  We have a number of additional patents pending and will continue to file new patents to extend the reach of our intellectual property.”


About Visualant, Inc.


Visualant™ is a public company whose shares trade under the stock symbol “VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. For more information on Visualant, visit the company’s website at www.visualant.net.


Visualant Press Contacts:


Hal Bringman

Email

hal@nvpr.com

Desk

+1 (206) 299-0622 ext 801

Mobile

+1 (310) 210-8011, Skype halbringman



GRAPHIC 3 visualant_logo.jpg GRAPHIC begin 644 visualant_logo.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_ MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`!*`(H#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`K M\S/VZ_VYO%7[#?Q&^">OZ_X&'Q`^`GQ/LO$WA_Q='H:"R\<^#/%?AF]T:_M= M7T'4+VY@\/ZT-=\/:[J*Q^$-9DTLZA/X7:ZL_$^@QP7Z:G^F=?$/_!0_]F.7 M]J_]EKQU\.-&MXI_'NB-:_$'X7^:Z1AO'GA6&\:RTQ9)KFUM(&\5:)?:]X+^ MVWLOV335\2-J/AB(-^RA0Q$IPJTE5I5/SOQ8H\95/#[B6OX>XZK@. M-AJ\FF^+O"\T[2QI:^ M*/"FHK;:[HCR36]S'9W-W9C3=56WDN]&OM2L#'=R>_U_G.>%O%?C/X<^)K+Q M1X,\1>*?`/C309YTL]<\.:KJOA;Q/HUSA[6]MDOM/FL=3LI&7S;._M&DC\Q# M-:W43(TD9_:+]G;_`(+F?'?P!'9:!^T#X1T7XXZ%$8X3XKTE[+P)\2+:)IE\ MRXO!86,G@SQ,+6T7RK2Q70O"=[(W5W\.[FXF((AM=+\::A=.P"^2&>-7_0G2=7TG7M-L]8T+5-.UK2-0A%Q8 M:KI-[;:CIM]`Q*K/9WUG+-:W,)96`DAE="5(#9!K^8\[X9XCX:Q#PO$.19OD MM?F<(PS/+\7A(U)1O=4:]2B\+B%9-WPV,Q,7'WD^5J3_`+2BXXS+\))3?(U[1.$=&BBBO M#/IPHHHH`**J7]_8Z79W&H:G>VFG6%I&9KJ^O[F&TL[:($`RW%S!_&EE\0?&&HQW-W)9^!(IO$^E:3I5A&'U M'6M<\4ZWM9A=:VM]-J-[8:78V5WJ5Y;VDGG8W.,IRVKA:&89G ME^"Q&.K4\-@<-B<9AJ.*QN(K35*E1P>%E6^MXJI.H^51PV%KV:DYSIQA.<.> MMC,)AI4J>(Q.'HU*\XTZ%.K6IPJUJDY=OAQ\3]94?%:RLH M(WMO!?Q/U68@>)I4MTCDM-`^)-P1-=WES'-#;?$)[]+S4Q<>-O#NEQ?C+X$O M=-:]?0]8L[*[M-3<&S:[MX93;ZCC:J122(7A^W1A8,QL':>.V4;0TC'_`$(? M'7@;PE\3/!WB7X?^/-"LO$W@WQAH]]H'B/0=160VFIZ5J,+07,#O!)#65_!/[1OQ&\/H)&>T7Q1X0 M\,^+IH%#EH1+/H]YX&,\D8VAI42W+LI<*F=H_KS@SQGX8S[PQQOAWXD9UFV1 MYAA,+3P/#_%>74,UQ&*H4\+#VF1X^6)RC$4,?A\QX?Q5##4)2C44/O!_)\KS3+>(*M?,N(N&<3F65Y7]3SBO5;S1X"G MFD883$9?GRK5L>Z4:M.>79I/%\L/J^(H.E^`EW\.?"]UGR[:ZL2QR397D@&2 M.-%N)_ M%A\.W_A]-)8VT@PZCJVI22BY-X)(?)/V ME/V'/&?[,GC33O".N>-K?QAI>L:+#JOAOQNOA*X\-VGB,6ZPV^N6\FE#Q!K\ M>G:KHNH21QW]G!JM\AL;_1]5S:KJT>GVGR'K%OXA^'^KQ_8]15);VQ+Q7<$$ M4D,D#7&V>V>*]@E7?'+;0R.-AVJ\)1L,17^<_C-]*'B;#<+\2\`0\4\\S/.L MNS*C2H9?F-*MF<)J8#&85U8T:]+'SJU,)F>#JJDX. MLJ'U_P!%?Z-'B5F?CAA,JX=PF0\`\587)<\J5JF>U5'"9C@5A\'3S?*J M.=IT"(=7\7^$I"4DMY%9BBYQD+VK$U/_@N9^SEXAT' M7M.^'G@+XVVGCVXT/5AX3_X2_P`(^"8O#UOKHL)VTV[UR;1?B9JUQ_9=M=B* M:[AMXFGNHT-K"\4DZ2K_`#=>/+JY\3W2ZEKD@O+V#2A8Q3K%;VFVWBFNIDC, M=G%!"Q$MU*P=D+G(4L550.7\*W?AWPO-J.HZC;ZA*YM$@M_L@A<"-I1+?\`!5S]HN>,K#XNALF(^_8?#OP<9`<8RHU.2^BR M3S\R,,]L<#D)?V_OVG/B-<2Z6]NL9:ZN=)M/"'@M+.)MPC!NO!VEZ= M>^=*P*0(EP9W(=]XBAEEC_-[X06VN_'?XF>#OA'\,_#FKZUXS\<:O'I.DV\\ M=M;6-I&L#;!0?,NKG3_"NMZO-(N*HX3`X.,_95LWQ^& MPV>8"$Z4)\V'P&'K5*4<9B^>4W]4P>(=3\V\)>-_&+QAKXG'Y9GF)Q_"^4XB M.&S3&X"D\/3Q.-E25>GE.'Q.)QN%A[9T90Q&-J4HU98/#3I*3AB,50C'X'TG M3/BK\??&FB^%;>]\7?$_QKK,_E:='XBU_5?$5U"J`&ZU"]U/7;R]_LS3+"(^ M=J6IW4\=O:P`&1R[Q1O_`$3_`+*W[+_AG]FOP6]A!);:WX]\0QVMQXW\6I`8 MA>W$"NUMHNCI*HGM/#>CM-,EA!)MGO)Y;C5+U4N+H6]MH?LU_LO^`_V;/#$F MG:"?[?\`&&KQ0_\`"6^/+ZRCM-4UV6([X[2SM1/>#0_#UI(2=/T*WO+I8C_I M.H7NJ:G)<:C/]*UYW@UX+1X+MQ3Q5*.9<;8RD^5U:TL=3R&E7ARU*-+%UJF( MGC,UJTY.EC$$DL-/\`%^ER_P!O>`M>OQ.EMIGB2UADC2UU">TA MN+N/0]=M9)]'UDQ6M^UK;W4>KV^FWVHZ3I\0_GK_`&UOV%?C'^SS^S]XI^/7 MC*Z\#^)?#_PQN-%O=;TWP%JOB'5_$BZ/XDUW2?"]W>VMEKGA/PS8266F7NJ: M;JVL32ZI#]BT?3[^^"2BW9#_`%3UYW\7?AIX?^,_PI^)7PA\5J[>&?BAX#\6 M_#_7C&H::/2?%^@W^@7T]MDKMNK>WOWGM)%='BN8XI8W1T5U_)./O!K@[CS& M5L\S'"8RGG\(F:8?'3I\-\29+B,XAEN-K8*MCN'OK<<%GV%E[" ME4E5JUN'LSSFA2:]Z%HM27LY4_P#.\U;]H3PS>QE+?0/$88H4S/\`V3$, M;@W2/4;CJ!COS7Z&_P#!/C]B+Q=_P45TWXHZSH?BZ+X0^#_AGJ?AC0I?$>M^ M&I?&`\3^(M>M-3U._P!$TJSL-=\/1V\OAG2;;1M2U=[G4"SIXHT);>,@W3QV M_!W_``;T_M]:Y!!)XD\1_LX>"0NR.Z35_B'XTU;4F(&UY[6S\,?#'6--E0L" MZQSZY:2;60,%;>$_J!_X)Q?L;']AC]F#0/@GJ6MZ-XI\:7'BGQ=XX^(7BKP_ M:7ECI'B#Q/XDU3R;&:RMM0)O5BT?P7I?A+PL)KD))>?V!]M\FU2X6UA[O`[/ M/%'@"OP_EV!IRR3A[ABGBL7EJS+)\KQ>(^N2JXBMA8.MC9XC$5I4L5F&)Q4' M5P\(TE1I)?PZ=_[N^G7X6_L_.(^`>-L9P'FE'Q!\5_$#-\DRC,GD/B9QOC\% M@,EC'#PS_,ZF&PF69-DM.E7R?(M65._M94N%_8`_X)O\` M@W]AL>-_$$WC1/BK\3/&H@TAO'$GA!/!R:#X(M_L-[_PB6CZ2_B/Q;<1+J.O M6O\`;'B#4_[9CCUHV/AJW?2[1O#T=Q>?I1117[3Q'Q)G?%N<8O/N(E3I0YJDE'GJU9U/\S^#^#>& M>`>'L!PKPAE-#))KU,3B:];$8JK7Q>*Q.(KU)5*V)Q5> MM7J.M9M?#G@CX?^%?$/C?QCXAOO M,^Q:#X5\*:1>:]XAUF\\I))?LNEZ187E]<>5'))Y,#[$=L*?R4_X*_\`AW5_ MA+H/[-G_``4F\":7?ZEXV_X)Z_&"U\:>/--T>WDO-7\6?LI?%H67PV_:8\*: M?8*HM9]2@\*WVE>,;#5=5?\`!2'XFZ-I?B3Q3X9U5X'T[]CCX9V&F?&#]HKQUX>UVT,M@\FM>";; MPYX)T:VO3_9_BB#X@SZ;;RO/-"K_`%N$X?PV/?#5?#U:M+`YC];H9U6FXU'E MN(R653&9S6C:,4J,LB]CF>#A--N4I4.>IHU\SB<[KX+^WJ-:E3GB\#]6JY32 M@I1^OT?MY_LZZ9\(?V5_CCJNM> M+=*\`?MF_$OX/_";X!76H^`O%=MJ_B;Q=\>8-0O/A8NJZ"VFG5/"^C>*--TZ M758=<\06]AIMIIMQ8W=[/`EY`&W/VJ/VU?V?_P!CG3?`TWQF\1:^?%'Q4UR_ M\,_";X7?#WP5XK^)_P`6_BGKVDV<6H:Q8>!/ASX&TG6_$NLQ:+9W-E)K>L-9 M6V@:++J>BV6JZM9W^O:):ZA^?O\`P6"TC2O#^A?\$F=`T+3K+1]$T/\`X+'? ML`:1HVD:9;0V6FZ5I6FW'Q`LM.T[3[.W2.WM+*QM((;:TMH(TA@@BCBB1415 M'5?MZ?"S]I+X:?M;?LW?\%$_V=?@Q'^U);_!/X6?%?X)_&/]GS3_`!!IWA_X MF2_#SX@WVC>(HOB3\"IM--!:S\'>'H/.UN\U M?0NO!Y)DN(_L+$5)UJ%'-X<75:>&Q&8X?"*O6RC,*>'R3+'F=>@L/@IXR-:G MA\3C:T/9RQ$;T_JSQ-&5'FQ6<9K0_MJC"%*K5RNIPU2G7H8*OB72HYG@'B>&/#^N^)-1NK,:)KOB?P/H_B#Q%?V\.I6^O:AJ M-L?G+_@F3_R=C_P6,_[/ET;_`-4EX$KDQ62X>G'B6<\!F>55LIP63XBC@,?6 MIU:M*MCLRH8/$.O%L6IZ MO8VD^F^'H[+PY$]U;3:S<6D>H3C[)9M-<90>G>-_&?ACX<>"_%_Q#\;:Q:^' MO!G@+POK_C/Q=K]\S+9:'X8\+Z3=ZYK^L7C(K,MKIFE6-W>W#*K,(8'(4D`' M\EOV]O\`E)I_P1/_`.RK_MG_`/K+FH5U?_!5'6]0^*MC^S3_`,$\O"EQ"HU6G)MU-1\MZ3D_TP^&OQ#\)?%WX<^`?BOX!U1=<\"_$W MP7X6^(/@O6EAFMEU?PIXRT.Q\1>'M3%M'S?*FC21 M64>=_P##2GPF'[3X_8]_MG4O^%ZGX"M^TH/#W]@ZO_9'_"IE^(2_"\ZS_P`) M1]D_L'^TO^$P86/]@_;O[7^R_P#$Q^R?8OWU?G]_P2ZUBX^"7BW]KO\`X)O^ M(I&@N/V//C%>>+?@+%<"X4:K^Q]^T?>:M\4O@U;Z;?:A(MSXBD^&.L7_`(S^ M%6OW6G6ZZ3X>'AWPWH4?V<&UMQS+?\K$,?\`VA>F_P#6XH*MY!AH9EQ#A)5* MT\-@.'\RSW*J\91B\3AU1R?&Y16J^[*,H5<%FT5B(0Y?]HH5X1G#V33E9U7E M@,BQ"A2CB,;G6`R?,:33DJ%=SS3"YE3I^\G&5/%Y8W0E*_[BM2DXRYTU^T-> M0_'3X\?"K]FSX2RT[4?B'XW\/?# M[PX]V+:.::*Q;Q'XGTI=2OO+-OI6FF\U:_>'3[&ZGB]>K\/_`-O_`.&>D_\` M!1?]K_X7_P#!./5[N7_A1WPJ^"/Q(_:F_:EN["*2X:/Q3\0/#'C'X!_LI^$+ M?4["[5=-\6:-XA\2?$/XZP^'M=C2TO[;X=^$]8,;!=.>7R\AR_#9CF-.GCZU M7#97AJ5?'YMB:,8RK4,NPD%/$2H1DG"6(J3JX;#X6$M*F(KTX:KFMZ.=8W$8 M'`5)X*E3KYC7J4L'EM"JVJ5;'8F3C159J47&A3C3K5L1--.%"E.5]D_W`KR/ MX>_'7X5_%+QK\9/AQX)\6V&K>//@!XPT?P/\7/"1\RUU[P?K7B/PCHOCKPS- M>Z?=)%/<:%XE\,:]9WV@>([);G0]4NK37M&M;]];\,>(].TKX\_X)5?'WQK\ MUGQ_\``^^C6&\30OB3 MI][I,7C#X(^-;2RN_P"S/&D5QH>NZ+X@TW7[1M#]?`\,4ZN-XDRS,,=3P6*R M>C".#Q4G'^S\1C*N:X3!818BM*WL*/ MB=XQT;P'X0M#I^C6MW>+;WOB37M-M;F]:$6MA!*]W=R16\4CCP#]H3_@H=\! M?V9OB.OPM^(GAK]HO5_$[:!I'B-9_A=^S#\=_BYX::PUNXU"VLH%\5_#KP)X MB\/MJ@ETVX^U:2-0.H6:O;/\;>$=52? M2?$&DFYNK9;F%;W2K_5=$O=,U:^_>ZN6IEN$RG"8'$9ME^-JXFICL^P&-P+Q ME*$XP49UNFGC\1F6)Q5++<9A88 M>&#RC&X7%K#K&0K4L?#&SJ-+ZQ0C*,XT*3IRYHNFU-2AS"[^^OM?_X1@RGQC;?# MB7PW!IVGZVL]CK.I2ZDMEH\ME?KJ,UN;*Z$7ZR5^+W_!O3_RA_\`V1O]_P#: M!_\`6H_C97[0U/%>$RS+<\S/*LLPV*H4LJS+,'PGU6&'>*PM. MO4I)O$8B55*52T9RY))1U3;=N8\;>#/"WQ'\&>+OAYXXT6S\2^"O'GAC7_!G MC#P[J*N^GZ_X6\4:5=Z'X@T6_2-XY&L]5TF^N[&Z6.2-V@G<(Z,0P_!S_@C_ M`/L@?'CX:_&'XQ>,/VH6U?5-3_8Q\&V__!-/]D_6M:M[[3I?$O[/'@7Q=J'Q M>7XLQZ7/YND3KX_\(^,/@GX2T76M&D6:QTKX9:CX9OW>:UN(H?Z"J*YSQ*J1YJ$<0M')8+%.6-PV_)B)SDDN9N7X^_\`!7WP MMXH\40?\$Q1X8\,^(O$I\._\%@OV'_%/B$>'M#U37/[`\+Z/J'C\ZOXFUS^R M[2Z_LCP[I(G@.IZYJ'V;2]/$\)O+N$2Q[O6OVC_VX/BE^R/^T'%:?&/]FOXB M>*/V*O%'@'1;G0/VE?@)X1\9?&;Q!\,?BA8ZGJR>+M%^/?PU\'Z3J7BGP[X% MU72I_#Y\(>+_``SHNM6]OJT)T^[;6[CQ)=V_P^_2BBMJ.=8?ZIE>`QV54O1C+ZKBL%4PL84)2I8NA5A5JQQ&'E&?N95< MIK_6LQQN#S&K@\3CZ^55[QP]"O2BLKP-?`_5Z]*JU]8PV+IUW*M&-3#UJWNHZ'' MH/AZ^GO8K@Z9J-]X8?Q/J6OQ%U[_`()A?MS?MG^,/C?\*?B[XB_9"_;4\6^` M?CKX!_:#^#_PR\:?&;3/A3\2-"\!Z9X%^)OP\^-WA[X=:-K_`(T\+)J^H:9I M6M^`-8M/#&H:)?Z7=+8P:CJ&J0^([;PO^]-%=T^**4Y?59Y4I9+_`&+0R'^S MY9AB)8SZKALQJYM0Q7]K.A[3Z]1S&M5K4F\$\%3P]267PPD<)9QY(\/5(+ZS M',7'-?[6JYS]"QT\1+%73 M_"#0/''BC_@I+_P44_8]^.GPB^$7Q?\`!/[(W["ND?'KQKJ/QU^,_P`.?%'P MBMOCU\3?C;\/4^%OAGP;\'?!GC[2_#_CW4M`\(6+ZGXE\0^-+S0K;2);JTOO M#=_;:/>1^'+CQ7Q>@_#_`/;S_:<_X*!?M3?MG_L]>)_@Q\'?"WP=^W?L"?!> M/]I_X(?%CQ;<>)?!'@'4/#OCSXO_`!*^'^F>&_B+\,]-D\/>.?C%>7FDZ+\0 M8V\0P>,/"OA#2K/3IK&ST=GU'^A.BFN*_8<\,%E."I4:>31R'`4<8YYI'#8" MKF-3,LSEB/K,!A@,!"BJ+JO#8;+Z4'*E3;Q%6O5?M<15]IJOYS/BS\/?V_OV M8OVVOV3/^"@7Q\\2_!7XU>'I]4LOV(OCK9?LK_`SXK>$/$&E?`/XSZMJNN^' MO'WCVT\1>/OBTVH^"O@_\9+?P]XLO;O0[/1]2L+?5+^TD_M"UU>>XTGJ_P!I MCXX:'^RC_P`%N](^/WQ-\!_&_6?A7JW_``2JL_A!:>)OA1\#_BA\7[9?B#JG M[7.M>,[;0+L?#SPQX@^PW">'/#.I:E7Y_2>,IK,'3Q^$H5Z&("_$GC[4M4^)O[ M+_QT^&GAN#P]X42SDUCR_$'C#P1I>G76K"*]CEL="M)I]7U18[@:?9W+P.@_ M,S]B7X._\%1?',?QP_;C^'GC']F?X#ZW^WM\4+[XOZA\/_VFOV>_BKXR^-G@ MKX5^#WOOA[^SM\/?$NJ^%_B[\-]*MM,\,?"72-(U;2M)D\,KJ5K>>+-9O-2O M#=ZE+I^G?T=45QT,_P`-E]+,*.4Y/AZ4,RC@:5=9K5_MM+#X.I5Q,Z$85Z&` MI\N)QKPN)G*47*'U*C2BIQE*4>NMDM?&U<#6S',JU2>7O%U*/]GTEEG^T8JG M3P\:\I0J8R:E0PJQ%""BTI?6ZLY2B[1E^`G[-7@7]KW]C[_@J)KMW^T3>_#_ M`.)'@G_@I=\/[S4?$'C']G?X4_$7P=\+/A]^T3^S%X7T>S\/7/C#3_%'B_XA M6G@.X^)WPHN=8LY]=N?$6GQ?$CQSIFC:?:::=3TJ:2Z^J?V'/#GB+1_VX?\` M@KIJ^K^'M>TG2/$_[1/[/M]X9U;5-&U+3M+\26-C^RI\,]-O;WP_J-Y:PV>M MVEEJ-O/I]YY^%7QY^/\`^S3XU_;D_9^T/2)M1L)_%7PT^.GP M^\8Z1^U]\.=!TY?.T/QU:6NAS>'OV@GT6!].\8^#;^7XF>*-(N=?\,:SXOA_ MI$HHKCS+/L7FN7Y3@<9&G.>4K%4Z>,2:Q.)HXA8.-*&,EK[>IA*6"I8:AB)- MUI82%"A6E4^JT*BZ,!D^&R[&YEC,-*I&&9?5I3PFGU?#5:#Q4JLL+%6]E#%5 M,5.O5H12I1Q$JU6FH?6*L#\>_P#@@=X6\4>"O^"37[*?AGQGX9\1>#_$NF/\ M>/[2\.>*]#U3PWK^G?;/VE_C+J%G]OT76K2RU.R^UV%W:WUK]IM8OM%E=6UW M#OMYXI'_`&$HHKFSG,99QF^:9M.E&A+,\QQF82H0G*I&C+&8BIB'2C4E&,IQ MINIRJ